Form D · Biotechnology
Siwa Corp
Chicago, IL · CIK 0001706026
Offering snapshot reported Aug 14, 2019 · SEC filing
- Reported sold
- Yet to sell Offering amount: $5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 14, 2019 | Initial | Yet to sell | No comparison | 2 | SEC filing |
| May 22, 2017 | Initial | $1,627,103 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-346574
Shares are offered at $16,0293 per share, subject to sale of a minimum (the "Minimum") of 187,157 shares ($3,000,000) and a maximum (the "Maximum") of 311,928 Shares ($5,000,000).
Source: Form D, filed Aug 14, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Alvarez | Executive |
| Lewis Steven Gruber | Director, Executive |
| Misty Sue Gruber | Director, Executive, Promoter |
| Alex Kormuschoff | Director |
| John Peters | Director |
| John Otto Peters Iii | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
400 E. Randolph Suite 705
Chicago, IL, 60601
Chicago, IL, 60601